The Fountain of Youth by Targeting Senescent Cells?

Lopez-Otin, 2013, The hallmarks of aging, Cell, 153, 1194, 10.1016/j.cell.2013.05.039 Vaupel, 2010, Biodemography of human ageing, Nature, 464, 536, 10.1038/nature08984 Muñoz-Espín, 2014, Cellular senescence: from physiology to pathology, Nat. Rev. Mol. Cell Biol., 15, 482, 10.1038/nrm3823 Tinkum, 2011, Bioluminescence imaging captures the expression and dynamics of endogenous p21 promoter activity in living mice and intact cells, Mol. Cel. Biol., 31, 3759, 10.1128/MCB.05243-11 Baker, 2011, Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders, Nature, 479, 232, 10.1038/nature10600 Burd, 2013, Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model, Cell, 152, 340, 10.1016/j.cell.2012.12.010 Demaria, 2014, An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA, Dev. Cell, 31, 722, 10.1016/j.devcel.2014.11.012 Ohtani, 2007, Visualizing the dynamics of p21(Waf1/Cip1) cyclin-dependent kinase inhibitor expression in living animals, Proc. Natl. Acad. Sci. U.S.A., 104, 15034, 10.1073/pnas.0706949104 Yamakoshi, 2009, Real-time in vivo imaging of p16Ink4a reveals cross talk with p53, J. Cell Biol., 186, 393, 10.1083/jcb.200904105 Baker, 2016, Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan, Nature, 530, 184, 10.1038/nature16932 Serrano, 1997, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a, Cell, 88, 593, 10.1016/S0092-8674(00)81902-9 Brown, 1997, Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts, Science, 277, 831, 10.1126/science.277.5327.831 Coppe, 2008, Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor, PLoS Biol., 6, 2853, 10.1371/journal.pbio.0060301 Kuilman, 2008, Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network, Cell, 133, 1019, 10.1016/j.cell.2008.03.039 Acosta, 2008, Chemokine signaling via the CXCR2 receptor reinforces senescence, Cell, 133, 1006, 10.1016/j.cell.2008.03.038 McCawley, 2008, Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment, Am. J. Pathol., 173, 1528, 10.2353/ajpath.2008.080132 Villeda, 2011, The ageing systemic milieu negatively regulates neurogenesis and cognitive function, Nature, 477, 90, 10.1038/nature10357 Franckhauser, 2008, Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice, Diabetologia, 51, 1306, 10.1007/s00125-008-0998-8 Storer, 2013, Senescence is a developmental mechanism that contributes to embryonic growth and patterning, Cell, 155, 1119, 10.1016/j.cell.2013.10.041 Munoz-Espin, 2013, Programmed cell senescence during mammalian embryonic development, Cell, 155, 1104, 10.1016/j.cell.2013.10.019 Niedernhofer, 2006, A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis, Nature, 444, 1038, 10.1038/nature05456 Vermeij, 2016, Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice, Nature, 537, 427, 10.1038/nature19329 Barnhoorn, 2014, Cell-autonomous progeroid changes in conditional mouse models for repair endonuclease XPG deficiency, PLoS Genet., 10, e1004686, 10.1371/journal.pgen.1004686 Murai, 2001, Early postnatal ataxia and abnormal cerebellar development in mice lacking xeroderma pigmentosum group A and Cockayne syndrome group B DNA repair genes, Proc. Natl. Acad. Sci. U.S.A., 98, 13379, 10.1073/pnas.231329598 de Boer, 1998, A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy, Mol. Cell, 1, 981, 10.1016/S1097-2765(00)80098-2 de Boer, 2002, Premature aging in mice deficient in DNA repair and transcription, Science, 296, 1276, 10.1126/science.1070174 Wijnhoven, 2005, Accelerated aging pathology in ad libitum fed Xpd(TTD) mice is accompanied by features suggestive of caloric restriction, DNA Repair (Amst), 4, 1314, 10.1016/j.dnarep.2005.07.002 Wiley, 2016, Mitochondrial dysfunction induces senescence with a distinct secretory phenotype, Cell Metab., 23, 303, 10.1016/j.cmet.2015.11.011 Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell, 134, 657, 10.1016/j.cell.2008.06.049 Krishnamurthy, 2004, Ink4a/Arf expression is a biomarker of aging, J. Clin. Invest., 114, 1299, 10.1172/JCI22475 Ferrucci, 2005, The origins of age-related proinflammatory state, Blood, 105, 2294, 10.1182/blood-2004-07-2599 Starr, 2009, Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6, J. Gerontol. A Biol. Sci. Med. Sci., 64, 723, 10.1093/gerona/glp046 Steiner, 2009, Interleukin-6 overexpression induces pulmonary hypertension, Circ. Res., 104, 236, 10.1161/CIRCRESAHA.108.182014 Franceschi, 2014, Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases, J. Gerontol. A Biol. Sci. Med. Sci., 69, S4, 10.1093/gerona/glu057 Baker, 2008, Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency, Nat. Cell Biol., 10, 825, 10.1038/ncb1744 Gregg, 2012, A mouse model of accelerated liver aging caused by a defect in DNA repair, Hepatology, 55, 609, 10.1002/hep.24713 Zhu, 2015, The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs, Aging Cell, 14, 644, 10.1111/acel.12344 Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med., 22, 78, 10.1038/nm.4010 Yosef, 2016, Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL, Nat. Commun., 7, 11190, 10.1038/ncomms11190 Chondrogianni, 2010, Anti-ageing and rejuvenating effects of quercetin, Exp. Gerontol., 45, 763, 10.1016/j.exger.2010.07.001 Talpaz, 2006, Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias, N. Engl. J. Med., 354, 2531, 10.1056/NEJMoa055229 Rudin, 2012, Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer, Clin. Cancer Res., 18, 3163, 10.1158/1078-0432.CCR-11-3090 Tait, 2010, Mitochondria and cell death: outer membrane permeabilization and beyond, Nat. Rev. Mol. Cell Biol., 11, 621, 10.1038/nrm2952 Evans, 2001, Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas, Pancreatology, 1, 254, 10.1159/000055820 Alireza, 2008, An immunohistochemistry study of tissue bcl-2 expression and its serum levels in breast cancer patients, Ann. N. Y. Acad. Sci., 1138, 114, 10.1196/annals.1414.017 Schoenwaelder, 2011, Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets, Blood, 118, 1663, 10.1182/blood-2011-04-347849 Wilson, 2010, Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity, Lancet Oncol., 11, 1149, 10.1016/S1470-2045(10)70261-8 Schmid, 2014, Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity, Cell Death Dis., 5, e1454, 10.1038/cddis.2014.413 Kaefer, 2014, Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia, Cancer Chemother. Pharmacol., 74, 593, 10.1007/s00280-014-2530-9 Di, 1994, DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts, Genes Dev., 8, 2540, 10.1101/gad.8.21.2540 Galanos, 2016, Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing, Nat. Cell Biol., 18, 777, 10.1038/ncb3378 Correia-Melo, 2016, Mitochondria are required for pro-ageing features of the senescent phenotype, EMBO J., 35, 724, 10.15252/embj.201592862 Coppe, 2011, Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype, J. Biol. Chem., 286, 36396, 10.1074/jbc.M111.257071 Hunter, 2015, IL-6 as a keystone cytokine in health and disease, Nat. Immunol., 16, 448, 10.1038/ni.3153 Di Paolo, 2016, Interleukin 1alpha and the inflammatory process, Nat. Immunol., 17, 906, 10.1038/ni.3503 Narita, 2003, Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence, Cell, 113, 703, 10.1016/S0092-8674(03)00401-X Kosar, 2011, Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a), Cell Cycle, 10, 457, 10.4161/cc.10.3.14707 Davalos, 2013, p53-dependent release of alarmin HMGB1 is a central mediator of senescent phenotypes, J. Cell Biol., 201, 613, 10.1083/jcb.201206006 Pluquet, 2015, The unfolded protein response and cellular senescence. A review in the theme: cellular mechanisms of endoplasmic reticulum stress signaling in health and disease, Am. J. Physiol. Cell Physiol., 308, C415, 10.1152/ajpcell.00334.2014 Young, 2009, Autophagy mediates the mitotic senescence transition, Genes Dev., 23, 798, 10.1101/gad.519709 Narita, 2009, Autophagy facilitates oncogene-induced senescence, Autophagy, 5, 1046, 10.4161/auto.5.7.9444 Laberge, 2015, MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation, Nat. Cell Biol., 17, 1049, 10.1038/ncb3195 Herranz, 2015, mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype, Nat. Cell Biol., 17, 1205, 10.1038/ncb3225 Pietras, 2016, Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal, Nat. Cell Biol., 18, 607, 10.1038/ncb3346 Orjalo, 2009, Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network, Proc. Natl. Acad. Sci. U.S.A., 106, 17031, 10.1073/pnas.0905299106 Brady, 2013, Early role for IL-6 signalling during generation of induced pluripotent stem cells revealed by heterokaryon RNA-Seq, Nat. Cell Biol., 15, 1244, 10.1038/ncb2835 Cahu, 2012, Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells, Cell Death Dis., 3, e446, 10.1038/cddis.2012.183 Chang, 2015, Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression, Clin. Cancer Res., 21, 201, 10.1158/1078-0432.CCR-13-3274 Medema, 2000, AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1, Nature, 404, 782, 10.1038/35008115 Salih, 2008, FoxO transcription factors in the maintenance of cellular homeostasis during aging, Curr. Opin. Cell Biol., 20, 126, 10.1016/j.ceb.2008.02.005 de Keizer, 2011, Forkhead box O as a sensor, mediator, and regulator of redox signaling, Antioxid. Redox Signal., 14, 1093, 10.1089/ars.2010.3403 Eijkelenboom, 2013, FOXOs: signalling integrators for homeostasis maintenance, Nat. Rev. Mol. Cell Biol., 14, 83, 10.1038/nrm3507 Chung, 2012, FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage, Nat. Commun., 3, 1000, 10.1038/ncomms2008 de Keizer, 2010, Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence, Cancer Res., 70, 8526, 10.1158/0008-5472.CAN-10-1563 Martinez, 2002, p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells, Carcinogenesis, 23, 1289, 10.1093/carcin/23.8.1289 Jackson, 2012, p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer, Cancer Cell, 21, 793, 10.1016/j.ccr.2012.04.027 Hong, 2009, Suppression of induced pluripotent stem cell generation by the p53-p21 pathway, Nature, 460, 1132, 10.1038/nature08235 Tschaharganeh, 2014, p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer, Cell, 158, 579, 10.1016/j.cell.2014.05.051 Nakae, 2003, The forkhead transcription factor Foxo1 regulates adipocyte differentiation, Dev. Cell, 4, 119, 10.1016/S1534-5807(02)00401-X Essers, 2005, Functional interaction between beta-catenin and FOXO in oxidative stress signaling, Science, 308, 1181, 10.1126/science.1109083 Hoogeboom, 2008, Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity, J. Biol. Chem., 283, 9224, 10.1074/jbc.M706638200 McClelland Descalzo, 2016, Glucose-induced oxidative stress reduces proliferation in embryonic stem cells via FOXO3A/beta-catenin-dependent transcription of p21(cip1), Stem Cell Reports, 7, 55, 10.1016/j.stemcr.2016.06.006 Wang, 2008, Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53, J. Mol. Biol., 384, 590, 10.1016/j.jmb.2008.09.025 Lönn, 2015, Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell, Expert Opin. Drug Deliv., 12, 1627, 10.1517/17425247.2015.1046431 Herce, 2007, Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes, Proc. Natl. Acad. Sci. U.S.A., 104, 20805, 10.1073/pnas.0706574105 Jones, 2012, Cell entry of cell penetrating peptides: tales of tails wagging dogs, J. Control. Release, 161, 582, 10.1016/j.jconrel.2012.04.003 Kruiswijk, 2016, Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling, Oncogene, 35, 2166, 10.1038/onc.2015.282 Borsello, 2003, A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia, Nat. Med., 9, 1180, 10.1038/nm911 Beydoun, 2015, Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study, J. Ocul. Pharmacol. Ther., 31, 93, 10.1089/jop.2013.0247 Deloche, 2014, XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study, Pharmacol. Res. Perspect., 2, e00020, 10.1002/prp2.20 Suckfuell, 2014, Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study, Otol. Neurotol., 35, 1317, 10.1097/MAO.0000000000000466 Warso, 2013, A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours, Br. J. Cancer, 108, 1061, 10.1038/bjc.2013.74 Filonov, 2011, Bright and stable near-infrared fluorescent protein for in vivo imaging, Nat. Biotechnol., 29, 757, 10.1038/nbt.1918 Ritsma, 2014, Intestinal crypt homeostasis revealed at single-stem-cell level by in vivo live imaging, Nature, 507, 362, 10.1038/nature12972 Mosteiro, 2016, Tissue damage and senescence provide critical signals for cellular reprogramming in vivo, Science, 354, 10.1126/science.aaf4445